goBalto raises $12 million in funding to expand its clinical study startup solutions. The San Francisco-based company specializes in streamlining the early phases of clinical trials for pharmaceutical and biotech firms. This investment supports its growth in a competitive healthcare technology sector.
Svelte Medical Systems secures $5 million in funding to advance its balloon-expandable stent technology. The New Providence, NJ-based company develops medical devices for vascular interventions. The investment supports further research and development in cardiovascular solutions.
goBalto, a San Francisco-based developer of cloud solutions, secures $12 million in venture funding to advance its platform for streamlining clinical trial operations. The company designs software aimed at improving efficiency in clinical research workflows. This funding round supports further product development and market expansion.
GlySens secures funding from the West Health Investment Fund to advance its implantable, long-term continuous glucose monitoring sensor. The San Diego-based company focuses on developing a device for improved diabetes management. This investment supports further research and development in wearable health technology.
Sep 2012FinSMEsNews article
West Health Investment Fund
West Health Investment Fund was launched as a founder-funded investment vehicle for healthcare technology and service companies.
